Abstract
Background:In October 2023, EULAR released updated recommendations for the management of systemic lupus erythematosus (SLE).2 Notably, since the previous guidelines update in 2019, anifrolumab received approval for treatment of SLE,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
